Clemedi AG

Making antibiotic resistance testing more comprehensive.

The current diagnosis of anti-microbial resistant infections is largely based on culturing bacteria in the presence of various antibiotics. This is both labor and time-consuming, leading to sub-optimal therapy and an increase in morbidity and mortality of the patient. We combine novel technologies - next-generation sequencing and machine learning, which will bring a quantum leap into how we diagnose infections and enable us to achieve targetted therapy instead.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

27.04.2023

The Biomedical Entrepreneurship ecosystem: Turning cutting-edge research into viable ventures (venturelab.swiss)

26.08.2022

Strong Swiss delegation at Medica (startupticker.ch)

25.08.2022

"Innovation needs diversity" — Interview with Maria Olivares of the Innovation Hub at the University of Zürich (venturelab.swiss)

No milestones

No Jobs

No videos and documents

Venture Kick

Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.

Venture Kick (30'000) 2018

Website